Patent ID: RE40707

Claim:
A method of decreasing a risk of mortality caused by congestive heart failure in a patient in need of such decrease, said method comprising: administering to said patient first dosages at least daily for a period of from 7 to 28 days, said first dosages each comprising carvedilol, then administering to said patient second dosages at least daily for a period of from 7 to 28 days, said second dosages each containing carvedilol, and then administering to said patient third dosages daily for a maintenance period to decrease a risk of mortality caused by congestive heart failure , said third dosages each comprising carvedilol, said maintenance period is greater than six months, and said third dosages each comprising a daily maintenance dose in the range of from about 10 mg to about 100 mg of carvedilol, said first dosages each comprising carvedilol in an amount which is 10-30% of said daily maintenance dose, said second dosages each comprising carvedilol in an amount which is 20-70% of said daily maintenance dose.